The primary importance of inflammation is illustrated by successful therapies using an IL-1 receptor antagonist and antibodies to monocyte chemotactic protein-1 in a monocrotaline (MCT)-induced PAH model [12]. The gene discussed is CCL2; the disease is pulmonary arterial hypertension.